Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
The Breast
Published October 1, 2026
Impact of anti-HER2 therapies on potentially avoidable deaths from stage II and III HER2-positive...
October 3, 2026
Medspoke
Medspoke
Hepatology
Published October 2, 2026
00:00
--:--
TESERA: morphologic subtyping and prognostic stratification of hepatocellular carcinoma from H&E ...
October 3, 2026
Share
TESERA: morphologic subtyping and prognostic stratification of hepatocellular carcinoma from H&E whole-slide images.
https://www.medspoke.co/channel_journal?id=785&tap_id=14974
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
European Journal of Cancer
Published September 29, 2026
Timing of first-line palliative systemic therapy in metastatic esophagogastric adenocarcinoma: A ...
October 3, 2026
Why are you reporting this TALK?